Efficacy and toxicity of eribulin treatment in metastatic breast cancer patients.

Efficacy and toxicity of eribulin treatment in metastatic breast cancer patients. Acta Oncol. 2018 Aug 11;:1-3 Authors: Brems-Eskildsen AS, Kristoffersen KB, Linnet S, Lörincz T, Langkjer ST PMID: 30101626 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30101626?dopt=Abstract

Source: Acta Oncologica - August 11, 2018 Category: Cancer & Oncology Authors: Brems-Eskildsen AS, Kristoffersen KB, Linnet S, Lörincz T, Langkjer ST Tags: Acta Oncol Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology | Toxicology